Compass Therapeutics Inc (NASDAQ: CMPX) kicked off on Monday, down -3.48% from the previous trading day, before settling in for the closing price of $5.17. Over the past 52 weeks, CMPX has traded in a range of $1.33-$5.86.
During the last 5-year period, the sales drop of Healthcare Sector giant was -104.70%. While this was happening, its average annual earnings per share was recorded -18.33%. With a float of $124.31 million, this company’s outstanding shares have now reached $177.57 million.
Compass Therapeutics Inc (CMPX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Compass Therapeutics Inc is 30.11%, while institutional ownership is 61.21%. The most recent insider transaction that took place on May 27 ’25, was worth 21,100. In this transaction CHIEF EXECUTIVE OFFICER of this company bought 10,000 shares at a rate of $2.11, taking the stock ownership to the 6,480,825 shares. Before that another transaction happened on Apr 09 ’25, when Company’s Director sold 3,571,428 for $1.59, making the entire transaction worth $5,678,571. This insider now owns 0 shares in total.
Compass Therapeutics Inc (CMPX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.11 earnings per share (EPS), lower than consensus estimate (set at -0.09) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.54% during the next five years compared to -104.70% drop over the previous five years of trading.
Compass Therapeutics Inc (NASDAQ: CMPX) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Compass Therapeutics Inc (CMPX)
Looking closely at Compass Therapeutics Inc (NASDAQ: CMPX), its last 5-days average volume was 1.44 million, which is a drop from its year-to-date volume of 1.52 million. As of the previous 9 days, the stock’s Stochastic %D was 50.44%.
During the past 100 days, Compass Therapeutics Inc’s (CMPX) raw stochastic average was set at 72.81%, which indicates a significant increase from 25.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.28 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.82, while its 200-day Moving Average is $3.26. However, in the short run, Compass Therapeutics Inc’s stock first resistance to watch stands at $5.28. Second resistance stands at $5.58. The third major resistance level sits at $5.79. If the price goes on to break the first support level at $4.77, it is likely to go to the next support level at $4.56. Now, if the price goes above the second support level, the third support stands at $4.26.
Compass Therapeutics Inc (NASDAQ: CMPX) Key Stats
The company with the Market Capitalisation of 887.53 million has total of 177,862K Shares Outstanding. Its annual sales at the moment are 850 K in contrast with the sum of -49,380 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -14,260 K.
